ENCOMPASS HEALTH CORP (EHC) Stock Balance Sheet
USA - New York Stock Exchange - NYSE:EHC - US29261A1007 - Common Stock
113.04 USD
-0.82 (-0.72%)
112.8 USD
-0.24 (-0.21%)
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 48.70M | 85.40M | 69.10M | 21.80M | 54.80M | |||
| Marketable Securities | 34.10M | N/A | N/A | N/A | N/A | |||
| Receivables | 610.80M | 598.80M | 611.60M | 536.80M | 680.30M | |||
| Other Current Assets | 176.20M | 202.70M | 161.10M | 158.60M | 186.30M | |||
| Total Current Assets | 869.80M | 886.90M | 841.80M | 717.20M | 921.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.14B | 3.85B | 3.51B | 3.15B | 2.84B | |||
| Investments And Advances | 105.70M | N/A | N/A | N/A | 4.00M | |||
| Goodwill | 1.30B | 1.28B | 1.28B | 1.26B | 2.43B | |||
| Intangibles | 291.90M | 297.80M | 278.20M | 282.30M | 417.50M | |||
| Other Non-Current Assets | 151.70M | 219.20M | 191.60M | 222.10M | 250.50M | |||
| Total Non-Current Assets | 6.00B | 5.65B | 5.26B | 4.92B | 5.94B | |||
| TOTAL ASSETS | 6.87B | 6.53B | 6.10B | 5.64B | 6.86B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 39.00M | 138.60M | 24.80M | 25.20M | 42.80M | |||
| Accrued Expenses | 584.60M | 292.80M | 274.20M | 236.70M | 348.70M | |||
| Accounts Payable | 138.40M | 171.00M | 170.00M | 132.90M | 137.60M | |||
| Other Current Liabilities | N/A | 238.60M | 187.40M | 181.10M | 219.70M | |||
| Total Current Liabilities | 762.00M | 841.00M | 656.40M | 575.90M | 748.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 2.39B | 2.36B | 2.69B | 2.74B | 3.24B | |||
| Deferred Taxes/Income | 107.50M | 105.20M | 87.00M | 83.00M | 86.70M | |||
| Other Non-Current Liabilities | 416.00M | 380.10M | 374.00M | 373.90M | 386.30M | |||
| Total Non-Current Liabilities | 3.73B | 3.63B | 3.80B | 3.75B | 4.20B | |||
| TOTAL LIABILITIES | 4.49B | 4.47B | 4.45B | 4.33B | 4.95B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 1.16B | 796.70M | 406.50M | 115.70M | 141.80M | |||
| Additional Paid In Capital | 1.85B | 1.85B | 1.79B | 1.73B | 2.29B | |||
| Minority Interest | 812.50M | 782.20M | 649.70M | 551.60M | 487.90M | |||
| Common Shares | 1.20M | 1.20M | 1.20M | 1.10M | 1.10M | |||
| Treasury Stock | -645.30M | -577.90M | -547.20M | -536.70M | -521.20M | |||
| Other Shareholders' Equity | 500.00K | N/A | N/A | N/A | 487.90M | |||
| Shares Outstanding | 100.62M | 100.78M | 100.25M | 99.80M | 99.50M | |||
| Tangible Book Value per Share | 7.74 | 4.81 | 0.88 | -2.36 | -9.39 | |||
| Total Shareholders' Equity | 2.37B | 2.07B | 1.65B | 1.31B | 1.91B | |||
| TOTAL LIABILITIES AND EQUITY | 6.87B | 6.53B | 6.10B | 5.64B | 6.86B | |||
| Statistics | ||||||||
| Debt/Equity | 1.01 | 1.14 | 1.63 | 2.09 | 1.70 | |||
| Current Ratio | 1.14 | 1.05 | 1.28 | 1.25 | 1.23 | |||
| Return On Assets (ROA) | 7.85% | 6.93% | 5.73% | 4.79% | 5.98% | |||
| Return On Equity (ROE) | 22.71% | 21.91% | 21.22% | 20.59% | 21.47% | |||
| Return On Invested Capital (ROIC) | 12.98% | 12.01% | 10.63% | 9.85% | 8.53% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 13.16% | 12.19% | 10.76% | 9.89% | 8.60% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 17.91% | 16.98% | 15.16% | 14.27% | 16.22% | |||
All data in USD , ROIC based on taxRate of 0.21